Ironwood Pharmaceuticals
IRWD
#7047
Rank
C$0.97 B
Marketcap
C$5.90
Share price
3.62%
Change (1 day)
236.28%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): C$0.23 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are C$0.36 Billion. In 2025 the company made an earning of C$96.38 Million, an increase over its 2024 earnings that were of C$89.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.23 B146.31%
2025 C$96.38 M7.4%
2024 C$89.73 M-106.88%
2023 -C$1.31 Billion-475.59%
2022 C$0.34 B25.8%
2021 C$0.27 B84.32%
2020 C$0.14 B84.69%
2019 C$81.12 M-125.13%
2018 -C$0.33 Billion100.62%
2017 -C$0.17 Billion43.12%
2016 -C$0.12 Billion-42.73%
2015 -C$0.2 Billion-24.76%
2014 -C$0.27 Billion-30.49%
2013 -C$0.38 Billion275.65%
2012 -C$99.96 Million11.56%
2011 -C$89.61 Million9.38%
2010 -C$81.92 Million-15.21%
2009 -C$96.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
C$20.18 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-C$0.21 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA